Measuring uncertainty in complex decision analysis models

Prediction models used in support of clinical and health policy decision making often need to consider the course of a disease over an extended period of time, and draw evidence from a broad knowledge base, including epidemiologic cohort and case control studies, randomized clinical trials, expert opinions, and more. This paper is a brief introduction to these complex decision models, their relation to Bayesian decision theory, and the tools typically used to describe the uncertainties involved. Concepts are illustrated throughout via a simplified tutorial.

[1]  G. Chapman,et al.  Decision Making in Health Care: Theory, Psychology, and Applications , 2003 .

[2]  A H Briggs,et al.  A Bayesian approach to stochastic cost-effectiveness analysis. , 1999, Health economics.

[3]  A J Moskowitz,et al.  Bayesian estimation of cost-effectiveness ratios from clinical trials. , 1999, Health economics.

[4]  M C Weinstein,et al.  Use and misuse of the term "cost effective" in medicine. , 1986, The New England journal of medicine.

[5]  Frank A. Sloan,et al.  Valuing health care , 1996 .

[6]  B. McNeil,et al.  Probabilistic Sensitivity Analysis Using Monte Carlo Simulation , 1985, Medical decision making : an international journal of the Society for Medical Decision Making.

[7]  A. Detsky,et al.  Evidence-based medicine. A new approach to teaching the practice of medicine. , 1992, JAMA.

[8]  Eric R. Ziegel,et al.  Modeling in Medical Decision Making , 2002, Technometrics.

[9]  Peter Green,et al.  Markov chain Monte Carlo in Practice , 1996 .

[10]  K Claxton,et al.  The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. , 1999, Journal of health economics.

[11]  G. DeFriese,et al.  The Stroke Prevention Patient Outcomes Research Team: Goals and Methods , 1993, Stroke.

[12]  P. Wakker,et al.  Confidence intervals for cost/effectiveness ratios. , 1995, Health economics.

[13]  M. Degroot Optimal Statistical Decisions , 1970 .

[14]  G. Torrance A generalized cost-effectiveness model for the evaluation of health programs , 1970 .

[15]  Robert M. Kaplan Valuing health care: Utility assessment for estimating quality-adjusted life years , 1995 .

[16]  E Laska,et al.  Statistical methods for cost-effectiveness analyses. , 1996, Controlled clinical trials.

[17]  A O'Hagan,et al.  A framework for cost-effectiveness analysis from clinical trial data. , 2001, Health economics.

[18]  Peter C. Fishburn,et al.  Utility theory for decision making , 1970 .

[19]  K. Manton,et al.  Chronic Disease Modelling: Measurement and Evaluation of the Risks of Chronic Disease Processes , 1988 .

[20]  J Lipscomb,et al.  Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke. , 1999, Journal of clinical epidemiology.

[21]  M. Gold Cost-effectiveness in health and medicine , 2016 .

[22]  J Lipscomb,et al.  Assessing Uncertainty in Cost-Effectiveness Analyses , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[23]  A. O'Hagan,et al.  Probabilistic sensitivity analysis of complex models: a Bayesian approach , 2004 .

[24]  S. Thompson,et al.  How should cost data in pragmatic randomised trials be analysed? , 2000, BMJ : British Medical Journal.

[25]  M J Al,et al.  Costs, effects and C/E-ratios alongside a clinical trial. , 1994, Health economics.

[26]  D. Sackett,et al.  Evidence based medicine: what it is and what it isn't , 1996, BMJ.

[27]  K E Willard,et al.  Probabilistic Analysis of Decision Trees Using Monte Carlo Simulation , 1986, Medical decision making : an international journal of the Society for Medical Decision Making.

[28]  Giovanni Parmigiani,et al.  On Optimal Screening Ages , 1993 .

[29]  M. Weinstein,et al.  Theoretical issues in cost-effectiveness analysis. , 1997, Journal of health economics.

[30]  Simon Thompson,et al.  Statistical issues in cost-effectiveness analyses. , 2002, Statistical methods in medical research.

[31]  A O'Hagan,et al.  Bayesian cost‐effectiveness analysis from clinical trial data , 2001, Statistics in medicine.

[32]  L. Goldman,et al.  Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. , 1987, American journal of public health.

[33]  John B. Kidd,et al.  Decisions with Multiple Objectives—Preferences and Value Tradeoffs , 1977 .

[34]  Howard Raiffa,et al.  Applied Statistical Decision Theory. , 1961 .

[35]  David Draper,et al.  Assessment and Propagation of Model Uncertainty , 2011 .

[36]  Anthony O'Hagan,et al.  The probability of cost-effectiveness , 2002, BMC medical research methodology.

[37]  A A Stinnett,et al.  Net Health Benefits , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[38]  Marek Ancukiewicz,et al.  Decision Models in Clinical Recommendations Development : the Stroke Prevention Policy , 1996 .

[39]  Frank A. Sloan,et al.  Valuing health care : costs, benefits, and effectiveness of pharmaceuticals and other medical technologies , 1995 .

[40]  Giovanni Parmigiani,et al.  The Stroke Prevention Policy Model: Linking Evidence and Clinical Decisions , 1997, Annals of Internal Medicine.

[41]  Joseph S. Pliskin,et al.  Utility Functions for Life Years and Health Status , 1980, Oper. Res..

[42]  Gregory K. Miller,et al.  Elements of Applied Stochastic Processes , 1972 .